ECOR
NASD electroCore, Inc.$10.14 ↑ +0.00 (+0.00%) Trading Up from the previous close of $10.14, $0.88 below the day’s high of $11.02
- YTD change
- +126.09%
- vs 20-day SMA
- -3.45%
- vs 200-day SMA
- +37.41%
Price ranges
Price & Performance
+3.10 (+44.03%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 96.7% away from all-time highs of $303.75
- ECOR is up 126% since the beginning of the year
- ECOR is up 98% over the past 12 months
- ECOR is up 7% over the past 1 month
- 4% of all ECOR investors are betting against ECOR
ECOR reads not so good: price sits above one of the two key moving averages, the 12-month move is +102.4%.
- Previous minute
- +$0.00
- Last hour
- -$0.11
- Last 5 days
- -10.66%
- vs 8-day SMA
- -9.08%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.